{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:51:33Z","timestamp":1792795893966,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SPF\/2021\/000199"],"award-info":[{"award-number":["SPF\/2021\/000199"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cellsig.2023.110738","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T15:39:37Z","timestamp":1685633977000},"page":"110738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Reduced YAP1 and FOLR1 in gliomas predict better response to chemotherapeutics"],"prefix":"10.1016","volume":"109","author":[{"given":"Shruti","family":"Patrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Lathoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellora","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2023.110738_bb0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2015.2","article-title":"DNA damage and the balance between survival and death in cancer biology","volume":"16","author":"Roos","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2023.110738_bb0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2023.110738_bb0015","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/ijc.30668","article-title":"DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy","volume":"140","author":"Ronchetti","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cellsig.2023.110738_bb0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2023.110738_bb0025","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Cancer Genome Atlas Research","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2023.110738_bb0030","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nature09132","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"465","author":"Dang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2023.110738_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2023.110738_bb0040","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.15252\/emmm.201707729","article-title":"Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways","volume":"9","author":"Fack","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cellsig.2023.110738_bb0045","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2009.21.9832","article-title":"Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas","volume":"27","author":"Sanson","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2023.110738_bb0050","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/neuonc\/not198","article-title":"Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry","volume":"16","author":"Tran","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.cellsig.2023.110738_bb0055","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/neuonc\/nou005","article-title":"The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone","volume":"16","author":"Molenaar","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.cellsig.2023.110738_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ccell.2016.05.018","article-title":"Mutant IDH1 downregulates ATM and alters DNA repair and sensitivity to DNA damage independent of TET2","volume":"30","author":"Inoue","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2023.110738_bb0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20181965","article-title":"Toward a better understanding of folate metabolism in health and disease","volume":"216","author":"Zheng","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellsig.2023.110738_bb0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tem.2021.12.003","article-title":"Emerging roles for folate receptor FOLR1 in signaling and cancer","volume":"33","author":"Nawaz","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cellsig.2023.110738_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/1354750X.2020.1771420","article-title":"A systematic review and meta-analysis of higher expression of folate receptor alpha (FOLR1) predicts poor cancer prognosis","volume":"25","author":"Liu","year":"2020","journal-title":"Biomarkers"},{"key":"10.1016\/j.cellsig.2023.110738_bb0080","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1021\/acsomega.0c05500","article-title":"Folate receptors\u2019 expression in gliomas may possess potential nanoparticle-based drug delivery opportunities","volume":"6","author":"McCord","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.cellsig.2023.110738_bb0085","article-title":"Folate receptor-alpha (FOLR1) expression and function in triple negative tumors","volume":"10","author":"Necela","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2023.110738_bb0090","first-page":"202","article-title":"Changes of folate receptor -alpha protein expression in human gliomas and its clinical relevance","volume":"52","author":"Wu","year":"2014","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.cellsig.2023.110738_bb0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","article-title":"The hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the drosophila homolog of YAP","volume":"122","author":"Huang","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2023.110738_bb0100","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.cellsig.2023.110738_bb0105","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/NEN.0b013e31821ff8d8","article-title":"Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth","volume":"70","author":"Orr","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cellsig.2023.110738_bb0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/path.5133","article-title":"Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence","volume":"246","author":"Guichet","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.cellsig.2023.110738_bb0115","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/s41388-021-01718-4","article-title":"YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer","volume":"40","author":"Lee","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2023.110738_bb0120","doi-asserted-by":"crossref","first-page":"98495","DOI":"10.18632\/oncotarget.21913","article-title":"YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways","volume":"8","author":"Andrade","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2023.110738_bb0125","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/febs.13604","article-title":"Hippo pathway and protection of genome stability in response to DNA damage","volume":"283","author":"Pefani","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.cellsig.2023.110738_bb0130","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.trecan.2020.05.004","article-title":"Senescent cells in cancer therapy: friends or foes?","volume":"6","author":"Wang","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cellsig.2023.110738_bb0135","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1909","article-title":"Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion","volume":"11","author":"Rodier","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellsig.2023.110738_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.729136","article-title":"DNA damage-induced inflammatory microenvironment and adult stem cell response","volume":"9","author":"Cinat","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cellsig.2023.110738_bb0145","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","article-title":"Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network","volume":"133","author":"Kuilman","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2023.110738_bb0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s10020-019-0103-4","article-title":"YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11","volume":"25","author":"Wang","year":"2019","journal-title":"Mol. Med."},{"key":"10.1016\/j.cellsig.2023.110738_bb0155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nature20602","article-title":"Integrin-YAP\/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow","volume":"540","author":"Wang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2023.110738_bb0160","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.259188","article-title":"YAP1-mediated regulation of mitochondrial dynamics in IDH1 mutant gliomas","volume":"134","author":"Patrick","year":"2021","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2023.110738_bb0165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2463","article-title":"2-hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity","volume":"9","author":"Sulkowski","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellsig.2023.110738_bb0170","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1158\/1541-7786.MCR-21-0284","article-title":"Monoallelic IDH1 R132H mutation mediates glioma cell response to anticancer therapies via induction of senescence","volume":"19","author":"Zhan","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110738_bb0175","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00001-18","article-title":"Mutant Isocitrate dehydrogenase 1 disrupts PKM2-beta-catenin-BRG1 transcriptional network-driven CD47 expression","volume":"38","author":"Gowda","year":"2018","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2023.110738_bb0180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/jnc.14152","article-title":"Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma","volume":"143","author":"Ahmad","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cellsig.2023.110738_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096801","article-title":"IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples","volume":"9","author":"Varghese","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2023.110738_bb0190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellsig.2023.110738_bb0195","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2023.110738_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese glioma genome atlas (CGGA): A comprehensive resource with functional genomic data from Chinese glioma patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.cellsig.2023.110738_bb0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/neuonc\/now247","article-title":"GlioVis data portal for visualization and analysis of brain tumor expression datasets","volume":"19","author":"Bowman","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.cellsig.2023.110738_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2023.110738_bb0215","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2023.110738_bb0220","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellsig.2023.110738_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","article-title":"One-carbon metabolism in health and disease","volume":"25","author":"Ducker","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2023.110738_bb0230","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/920161","article-title":"H2AX phosphorylation: its role in DNA damage response and cancer therapy","volume":"2010","author":"Podhorecka","year":"2010","journal-title":"J. Nucleic Acids"},{"key":"10.1016\/j.cellsig.2023.110738_bb0235","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/onc.2015.219","article-title":"YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage","volume":"35","author":"Ciamporcero","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2023.110738_bb0240","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1038\/s41388-021-01878-3","article-title":"Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2023.110738_bb0245","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1038\/s41598-017-07632-8","article-title":"Verteporfin inhibits growth of human glioma in vitro without light activation","volume":"7","author":"Al-Moujahed","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2023.110738_bb0250","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ejca.2009.10.014","article-title":"Enzastaurin induces H2AX phosphorylation to regulate apoptosis via MAPK signalling in malignant glioma cells","volume":"46","author":"Jane","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cellsig.2023.110738_bb0255","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1158\/1535-7163.MCT-10-0010","article-title":"Minimally cytotoxic doses of temozolomide produce radiosensitization in human glioblastoma cells regardless of MGMT expression","volume":"9","author":"Bobola","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellsig.2023.110738_bb0260","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2011.12.025","article-title":"Use of the gamma-H2AX assay to monitor DNA damage and repair in translational cancer research","volume":"327","author":"Ivashkevich","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2023.110738_bb0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1471-2407-13-147","article-title":"Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells","volume":"13","author":"Filippi-Chiela","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2023.110738_bb0270","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4161\/cbt.8.5.7740","article-title":"Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide","volume":"8","author":"Sato","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cellsig.2023.110738_bb0275","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1158\/1078-0432.CCR-06-1920","article-title":"Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide","volume":"13","author":"Fishel","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2023.110738_bb0280","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2018.03.025","article-title":"XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repair","volume":"424","author":"Roos","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2023.110738_bb0285","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1349-7006.2011.02134.x","article-title":"IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma","volume":"103","author":"SongTao","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellsig.2023.110738_bb0290","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fonc.2018.00164","article-title":"Non-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy","volume":"8","author":"Saleh","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2023.110738_bb0295","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/stem.188","article-title":"Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth","volume":"27","author":"Wang","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.cellsig.2023.110738_bb0300","article-title":"Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma","volume":"3","author":"Holst","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.cellsig.2023.110738_bb0305","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/labinvest.2017.19","article-title":"Immune microenvironment of gliomas","volume":"97","author":"Gieryng","year":"2017","journal-title":"Lab. Investig."},{"key":"10.1016\/j.cellsig.2023.110738_bb0310","doi-asserted-by":"crossref","first-page":"1779990","DOI":"10.1080\/2162402X.2020.1779990","article-title":"Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma","volume":"9","author":"Marinari","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cellsig.2023.110738_bb0315","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12864-022-08586-6","article-title":"Association between high immune activity and worse prognosis in uveal melanoma and low-grade glioma in TCGA transcriptomic data","volume":"23","author":"Matsuo","year":"2022","journal-title":"BMC Genomics"},{"key":"10.1016\/j.cellsig.2023.110738_bb0320","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1101\/gad.294991.116","article-title":"Mutant IDH1 regulates the tumor-associated immune system in gliomas","volume":"31","author":"Amankulor","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.cellsig.2023.110738_bb0325","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52176","article-title":"Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies","volume":"9","author":"Pombo Antunes","year":"2020","journal-title":"Elife"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823001523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656823001523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:11:22Z","timestamp":1760267482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656823001523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":65,"alternative-id":["S0898656823001523"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110738","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced YAP1 and FOLR1 in gliomas predict better response to chemotherapeutics","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2023.110738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110738"}}